相关实验视频

Updated: Jul 27, 2025

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

临床特征和LMNA突变相关脂质缩的潜在分子机制

Cheng Xiao¹, Jieying Liu^1,2, Chunru Yang¹

¹Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Advanced biology

|June 12, 2023

概括

这项研究揭示了四种LMNA突变导致脂质营养不良和代谢问题. 突变的拉明A/C蛋白是不稳定的,通过无素-蛋白酶系统 (UPS) 降解.

科学领域:

遗传学和分子生物学
细胞生物学细胞生物学
内分泌学在内分泌学.

背景情况:

脂质缩是一种罕见的疾病,其特点是脂肪组织的损失.
LMNA基因的突变是已知的遗传性脂质营养不良的原因.
了解基因型-表型相关性和分子机制对于诊断和治疗至关重要.

研究的目的:

为了研究LMNA突变相关的脂质变的基因型-表型相关性.
为了阐明这种情况背后的分子机制.
为了确定潜在的治疗目标.

主要方法:

对6名患有LMNA突变相关脂质变的患者的临床数据分析.
鉴定和描述四种不同的LMNA突变.
在体外研究中,使用感染LMNA突变等离子体的HEK293细胞.
对突变的Lamin A/C蛋白稳定性和降解途径 (ubiquitin-proteasome系统) 的评估.
使用共聚焦显微镜分析核结构.

主要成果:

在6名患者中发现了4种独特的LMNA突变,所有患者都表现出脂质和代谢障碍.
两名患者表现出心脏功能障碍;用于血糖控制的药物是甲福林和皮奥格利塔.
突变的拉敏A/C蛋白显示稳定性显著降低,并通过全素-蛋白酶体系统降解.
聚焦显微镜检测出核泡和受影响细胞中不规则的细胞膜.

结论:

LMNA突变与多种类型的脂质变现象有关,包括代谢和心脏并发症.
通过UPS降低突变Lamin A/C的稳定性和增加降解是关键的分子机制.
这项研究提供了关于LMNA相关脂质变的病原体的见解,并提出了潜在的治疗途径.

关键词:

与LMNA突变相关的脂质变.拉明A/C A/C 是一个类型.分子机制的分子机制.乌比奎丁-蛋白酶体系统

更多相关视频

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture

Preparation of 3D Decellularized Matrices from Fetal Mouse Skeletal Muscle for Cell Culture

Published on: March 3, 2023

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

相关概念视频

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...